The dependence of GBM on de novo lipogenesis is governed by increased oncogenic activity, which in turn stimulates sterol regulatory element-binding protein-1 (SREBP-1), a transcription factor, and master regulator of lipogenesis [102,103]. The gene discussed is SREBF1; the disease is glioblastoma.